Yeni tıbbi cihaz düzenlemelerinin yürürlüğe girmesi hakkında duyuru saglikaktuel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saglikaktuel.com Daily Mail and Mail on Sunday newspapers.
PAVmed Inc. [NASDAQ: PAVM] price surged by 7.79 percent to reach at $0.37. The company report on May 26, 2021 that PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device. Get the hottest stocks to trade every day before the market ope
PAVmed Receives European CE Mark Certification for its CarpX® Minimally Invasive Carpal Tunnel Device
May 25, 2021 09:30 ET | Source: PAVmed Inc. PAVmed Inc.
NEW YORK, May 25, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that it has received CE Mark certification for its CarpX
® minimally invasive carpal tunnel device.
EU-based Notified Body TÜV Rhineland LGA Products GMBH issued a CE Certificate, effective May 24, 2021, declaring that CarpX conforms to the essential requirements of Medical Device Directive 93/42/EEC. With CE Mark secured, CarpX may now be marketed in CE Mark European countries, which include the European Economic Area (the EU, Norway, Iceland and Lichtenstein), Switzerland, and, until July 1, 2023, the United Kingdom.
SciBase receives important European MDR certification
STOCKHOLM, May 10, 2021 /PRNewswire/
SciBase Holding AB ( SciBase ) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that it has been granted certification under the new Medical Device Regulation (MDR).
MDR is a set of mandatory legal requirements central for all companies selling medical devices in the EU. The new regulation comes into effect on May 26
th. SciBase is one of very few medical device manufacturers to have completed the MDR certification, after an intensive two year process. With the MDR Certification in place SciBase can release new products, indications and functionality such as their new Non-melanoma Skin cancer (NMSC) application.
Neovasc Announces First Quarter 2021 Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.